2-8C (35.6-46.4F) short-term Reconstituted (Liquid Form) Tesamorelin + Ipamorelin Blend 35.6-46.4F (2-8C), protected from light Appearance Tesamorelin + Ipamorelin Blend Clear after reconstitution Do not freeze reconstituted solution
The proportion of patients who had ongoing treatment, regardless of previous discontinuation episodes, ranged between approximately 70% and 80% for both drugs during a 15 year period after treatment initiation across analyses using various grace periods
J Endocrinol Invest 42:11251131 Paccou J, Yavropoulou MP, Naciu AM, Chandran M, Messina OD, Rolvien T, Carey JJ, Doronzo S, Anastasilakis AD, Saag KG, Lems WF (2024) Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society
In other products, the active peptide can also be manufactured using recombinant technologies by expressing the active peptide in a cell-based system such as yeast cells or mammalian cells, followed by subsequent purification and formulation, he says